Pages that link to "Q42997168"
Jump to navigation
Jump to search
The following pages link to Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3. (Q42997168):
Displaying 17 items.
- Dendritic Cell Function during Chronic Hepatitis C Virus and Human Immunodeficiency Virus Type 1 Infection (Q27481412) (← links)
- Regulatory dendritic cells: there is more than just immune activation (Q28388235) (← links)
- A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals (Q34091925) (← links)
- Vaccination with dendritic cells pulsed with hepatitis C pseudo particles induces specific immune responses in mice. (Q35776114) (← links)
- Current status and future directions in the management of chronic hepatitis C. (Q35887719) (← links)
- Blood safety and the choice of anti-hemophilic factor concentrate (Q36488803) (← links)
- Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments (Q36900143) (← links)
- Construction and Immunogenicity Analysis of Hepatitis C Virus (HCV) Truncated Non-Structural Protein 3 (NS3) Plasmid Vaccine. (Q36928419) (← links)
- Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein. (Q40070362) (← links)
- Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection (Q40701361) (← links)
- Hepatitis C virus modulates human monocyte-derived dendritic cells (Q41785343) (← links)
- Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3 (Q42181972) (← links)
- HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo (Q43000308) (← links)
- Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA. (Q43035267) (← links)
- Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity (Q43047446) (← links)
- A safety study of a B-class CpG ODN in Sprague-Dawley rats (Q44349028) (← links)
- Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression (Q56987707) (← links)